1Loletta KY So, Arthur CW, Loretta YCY Am,et al. Development of a standard treatment protocol for severe acute respiratory syndrome [ J ].Lancet,2003.361 : 1615 - 1617.
2Tanita T, Song C, Kubo H, et al. Superoxide anion mediates pulmonary vascular permeability caused by ,neutrophils in cardiopulmonary bypass[J] .Surg Today, 1999,29:755 - 761.
3Larson DF, Bowers M, Schechner HW, et al. Neutrophil activation during cardiopulmonary bypass in pediatric and adult patients [ J ]. Perfusion,1996,11:21-27.
4Miura M,Sugiura T,Aimi Y. Effects of ulinastatin on PMNL and vascular endothelial injury in patients undergoing open heart surgery with CPB[J].Masui, 1998,47:29 - 35.
5Hiyama A,Takeda J, Kotate Y, et al. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass[J] .J Cardiothorac Vase Anesth, 1997,11:580 -584.
6Watanabe A, Sumita S, Ichimiya T, et al. Effect of ulinastatin on extravascular lung water volume in patients undergoing cardiopulmonary bypass[J]. Masui, 1994,43( 1 ) :78 - 88.
